Serenus Biotherapeutics Limited
Company Summary
Serenus Biotherapeutics Limited was set up on Friday the 30th of January 2015. Their current partial address is Mercer Street Lower, and the company status is Dissolved with the company closing on Sunday the 26th of January 2025. The company's current directors have been the director of 15 other Irish companies between them; 10 of which are now closed. Serenus Biotherapeutics Limited has 3 shareholders. This Irish company shares its Eircode with at least 424 other companies.
| Company Name: | Serenus Biotherapeutics Limited |
| Company Status: | DISSOLVED |
| Company Address: | Bdo Simpson Xavier, Beaux Lane House, Mercer Street Lower, , Ireland |
| Company Size: | Log-In To View |
| Established: | 30/01/2015 (10 years in business). |
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
Latest Updates
The latest documents filed with the Companies Registration Office for Serenus Biotherapeutics Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form E5: Liquidator`s Final Statement of Accounts | 17/10/2024 | 24/10/2024 | Join Up | |
| Form E6: Return of final winding up meeting | 17/10/2024 | 24/10/2024 | Join Up | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 17/10/2024 | 24/10/2024 | Join Up | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 20/07/2024 | 24/10/2024 | Join Up | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 20/01/2024 | 24/10/2024 | Join Up | |
| THIS COMPANY HAS 61 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
Credit Report
View the Latest Credit Report and Credit Limit on Serenus Biotherapeutics Limited.
| Company Status: | Dissolved |
| Latest Credit Movement: |  |
| Date of Last Movement: | 05/08/2025 |
| Latest Accounts Filed: | 27/10/2020 |
| Report Based on Accounts: | 31/12/2019 |
| Next Set of Accounts Due: | 30/09/2021 |
| Overdue: | Yes |
| Credit Score: | Join-Up to View |
Full Credit Rating
To View the latest Credit Rating or Credit Limit on Serenus Biotherapeutics Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Directors & Owners
Satisfy due diligence requirements on Serenus Biotherapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Serenus Biotherapeutics Limited and Anti-Money Laundering checks (AML checks) on Serenus Biotherapeutics Limited
Directors details are available to logged in users.
Ownership Structure
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 3 |
Compliance
Log-in now to run Due Diligence checks and Compliance checks on Serenus Biotherapeutics Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
Ask Us A Question...?
More people choose Vision-net over any other search service... ask us why?
RiskWatch: Earlier Visibility, Better Decisions
29/05/2026
Financial distress rarely appears without warning.
PEP and Sanctions Screening: Keeping Pace with Changing Risk
25/05/2026
PEP and sanctions screening is becoming more complex as risk evolves across markets and jurisdictions.
Fitness and Probity: Continuous Accountability
18/05/2026
Fitness and Probity has returned to the forefront in recent weeks, driven by renewed regulatory emphasis on how firms apply these standards under the Individual Accountability Framework (IAF).
AML Compliance: What Businesses Need to Be Ready For
13/05/2026
AML Compliance: What Businesses Need to Be Ready For